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Abstract
We report a technology to form human embryoid bodies (hEBs) from singularized human embryonic stem cells (hESCs)
without the use of the p160 rho-associated coiled-coil kinase inhibitor (ROCKi) or centrifugation (spin). hEB formation was
tested under four conditions: +ROCKi/+spin, +ROCKi/-spin, -ROCKi/+spin, and -ROCKi/-spin. Cell suspensions of BG01V/hOG
and H9 hESC lines were pipetted into non-adherent hydrogel substrates containing defined microwell arrays. hEBs of
consistent size and spherical geometry can be formed in each of the four conditions, including the -ROCKi/-spin condition.
The hEBs formed under the -ROCKi/-spin condition differentiated to develop the three embryonic germ layers and tissues
derived from each of the germ layers. This simplified hEB production technique offers homogeneity in hEB size and shape to
support synchronous differentiation, elimination of the ROCKi xeno-factor and rate-limiting centrifugation treatment, and
low-cost scalability, which will directly support automated, large-scale production of hEBs and hESC-derived cells needed for
clinical, research, or therapeutic applications.
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Introduction
Human embryonic stem cells (hESCs) are pluripotent, with the
ability to differentiate into all somatic and germ cell types in the
body. As a result, hESCs have widespread implications for human
developmental biology and cell biology, drug discovery, and
transplantation medicine for human tissue regeneration [1,2].
Protocols have been developed to induce differentiation of hESCs
into a wide variety of cell types, including hematopoietic cells
[3,4], cardiomyocytes [5,6], neural progenitors and functional
neurons [7–9], hepatocytes [10,11], and pancreatic beta cells
[12,13], among others. A significant challenge for the clinical
translation of hESC research successes in vitro and in animal
models is the efficient production of a sufficient number of
differentiated cells needed for patient treatment. Key requirements
for clinical translation include the delivery of a homogeneous,
functional cell population [14], defined xeno-free culture condi-
tions [9], and easy scale-up with automation technology to meet
demand in a cost-effective manner [15].
Formation of an embryoid body (hEB) is the first step in hESC
differentiation protocols [16,17]. In three-dimensional aggregates,
hESCs form cell-cell contacts, spontaneously differentiate to form
the three embryonic germ layers of endoderm, mesoderm, and
ectoterm, and recapitulate features of pregastulation and early
gastrulation [16,18]. Because hESCs have low survival rates as
dissociated single cells [19], hEBs have typically been formed using
hESC colonies or colony pieces that are cultured in suspension
[16,20] or in hanging drops [17,21] to promote aggregation.
However, thus-derived hEBs have both pre-existing and newly
formed cell-cell contacts, and exhibit a broad size distribution and
irregular geometries, both of which are associated with asynchro-
nous differentiation [15], and reduced homogeneity and repro-
ducibility of the resulting cell population [22,23].
More recent approaches to hEB formation have used dissoci-
ated single-cell suspension of hESCs as the input population.
Treatment with the p160 Rho-associated coiled-coil kinase
(ROCK) inhibitor (ROCKi, Y-27632) has been widely used to
promote survival of dissociated hESCs after passages [19] and
assist EB formation from dissociated single-cell suspension of
hESCs [15,24]. The exact mechanism by which ROCKi promotes
hESC survival and hEB formation is unknown; yet, evidence
suggests that ROCKi may prevent anoikis associated with loss of
cell-cell contacts [25,26]. Nonetheless, ROCKi is a xeno-factor
with little known about its potential downstream effects. ROCKi
has been shown to bias cell fate toward residual pluripotency in
neural differentiation studies, making these cells unsuitable for cell
therapies [8]. In addition to heavy dependence of hEB formation
on the presence of ROCKi, most protocols have applied
centrifugation as a means to force cell aggregation [27,28].
Although centrifugation may avoid exposure of hESCs to the
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ROCKi xeno-factor, it is not conducive to high throughput,
automated production of hEBs.
When compared to cell colonies/clumps, dissociated single cell
suspension represents a more uniform inputting population that
makes robotic time-efficient large-scale production of hEBs
possible to meet the demand of real-world applications. To form
hEBs in large quantities from dissociated single-cell suspension of
hESCs, researchers have recently turned to molds or plates that
contain an array of microwells [15,27–29]. To date, microwell-
based hEB formation from dissociated hESCs in other labs has
indicated no success in the absence of ROCKi or centrifugation
[15,27–29], likely due at least in part to the lack of efficient cell
aggregation and control of cell-cell signaling and colony charac-
teristics that are crucial for hESC survival, growth, and
differentiation.
Here, we report a technology to form hEBs from singularized
hESCs without the use of ROCKi or centrifugation. hEB
formation was tested under four conditions: +ROCKi/+spin,
+ROCKi/-spin, -ROCKi/+spin, and -ROCKi/-spin. Dissociated
single cell suspension of hESCs was pipetted into non-adherent
hydrogel molds containing defined micro-well arrays. For both
tested hESC lines, i.e., BG01V/hOG (Invitrogen), and feeder-free
H9 (WiCell Research Institute), hEBs of consistent size and
spherical geometry were formed in each of the four conditions,
including the -ROCKi/-spin condition. The hEBs formed without
ROCKi and spin differentiated to develop the three embryonic
germ layers and tissues derived from each of the germ layers. This
simplified hEB production technology offers homogeneity in hEB
size and shape to support synchronous differentiation, elimination
of the ROCKi xeno-factor and rate-limiting centrifugation
treatment, and low-cost scalability, which will directly support
automated, large-scale production of hESC-derived cells needed
for clinical, research, or therapeutic applications.
In addition to the technical advances pertinent to stem cell
therapeutics, this study will gain insight into human embryogenesis
especially cellular differentiation hierarchy, of which our knowl-
edge is very rudimentary. Assess to various stages of human
embryonic development would not be feasible due to both
practical and ethical reasons, yet, model systems that allow direct
observation of human developmental process are currently not
available. hEBs address this critical need by offering a model
system to study human development as well as a source of
differentiated cells for scientific and clinical interest. Controlled
reproducible high throughput production of uniform-sized hEBs
as achieved using this approach represents a platform to
recapitulate aspects of human developmental processes in vitro
in which interplays among endogenous and exogenous factors
during embryogenesis, hEB-mediated differentiation, and tissue
formation are essential. Further, successful generation of homog-
enous hEBs using our method that is free of ROCKi treatment or
centrifugation has for the first time questioned the conventional
concept regarding the necessity of ROCKi for hESC survival in
single-cell suspension and hEB formation. Elucidating the key
environmental factors to hESC survival, proliferation, and
directed synchronous differentiation, as well as administering
these factors using an engineering approach lays the foundations




BG01V/hOG (Invitrogen – R7799-105) and feeder-free H9
(WiCell Research Institute – Lot WB007–WA09) hESC lines were
cultured according to supplier protocols. BG01V/hOG hESCs
were expanded on a feeder layer of mitomycin C-inactivated
(10 mg/ml, Invitrogen) mouse embryonic fibroblasts (MEFs,
Millipore) in hESC medium (DMEM/F12 with 2 mM GLUTA-
MAX (Invitrogen), 20% (v/v) knockout serum replacement
(Invitrogen), 0.1 mM nonessential amino acids (Invitrogen),
55 mM b-mercaptoethanol (Gibco), 4 ng/ml recombinant human
bFGF (Inivitrogen), and 50 mg/ml hygromycin B (Invitrogen)).
hESC colonies were passaged by cutting them into uniform pieces
(StemPro EZPassage tool, Invitrogen). Following initial expansion,
BG01V/hOG hESC were switched to matrigel (Growth Factor
Reduced Matrigel, BD Bioscences) and expanded in chemically
defined mTeSR1 medium (mTeSR1 Basal Medium with mTeSR1
5X supplement, Stem Cell Technologies). BG01V/hOG hESC
were passaged five times to eliminate MEF from the culture. H9
hESC are cultured under a feeder-free condition. Their expansion
protocol was the same as that for the feeder-free culture of the
BG01V/hOG hESC. H9 colonies were passaged using 0.2 g/L
Versene (EDTA) (Lonza). BG01V/hOG and H9 hESC colonies
were incubated with Accutase (Innovative Cell Technologies) for
5 min at 37uC to form single cell suspensions.
Fabrication of hydrogel microwells using stamps with
micronipple arrays, and hEB formation
The stamp with micronipple arrays (Fig. S1) were first designed
with a computer-aided design program (SolidWorks) to generate
STereoLithography (STL) file, which was transferred to computer
numerical controlled (CNC) ultra-high precision lathe (Siemens) to
fabricate the micronipples at the Teflon stamp surface. Each
micronipple was highly polished. Agarose (Sigma Aldrich) solution
(2% w/w) was prepared in phosphate buffered saline (PBS) by
heating to 50uC and pipetted into the culturewares, such as
multiwall plates, and culture dishes. Then the stamp with
micronipple arrays was pressed into the Agarose solution at room
temperature for 2 minutes. High-quality uniform-sized microwells
were imprinted in the Agarose hydrogels. The size of microwells
can be well controlled through the use of stamps of different sized
micronipples. In this study, the size of each microwell was 820 mm
in diameter and 1300 mm in depth. Arrays were equilibrated with
hEB culture medium (Iscove’s Modified Dulbecco’s Medium (1:1
IMDM (Invitrogen) and F-12 Nutrient Mixture (Ham) (Invitro-
gen)), 5% fetal bovine serum (Gibco), 1% (v/v) insulin transferrin
selenium-A supplement (Invitrogen), 55 mM monothioglycerol
(Sigma Aldrich), 100 U/ml penicillin, and 0.1 mg/ml streptomy-
cin (Gibco)) overnight at 37uC and 5% CO2.
For hEB formation, 50 ml of hESC suspension was pipetted into
microwell arrays (Fig. S1). The suspension was allowed to
sediment into the microwells for 10 min before additional medium
was added. hEB formation was tested over the range of 10,000 to
35,000 hESCs per microwell in increments of 5,000 hESCs for
each hESC cell lines.
Two treatments to promote hEB formation, the addition of
ROCKi and centrifugation (spin), were examined as controls. In
total, four treatment conditions were tested: +ROCKi/+spin, +
ROCKi/-spin, -ROCKi/+spin, and -ROCKi/-spin. For the
ROCKi treatment, 10 mM of ROCKi was added to the
differentiation media. For the centrifugation treatment, the
microwell arrays were centrifuged at 200 g for 5 min after cell
suspension sedimentation.
hEB viability
After 24-hr incubation in the microwell array, viabilities of hEBs
and non-aggregated hESCs were evaluated by LIVE/DEAD
staining (Catalog # L-7013, Molecular Probes) according to
Embryoid Body Formation without ROCK Inhibitor
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manufacturer instructions. Fluorescent images were acquired using
a stereo fluorescent microscope (Eppendorf) and a confocal
microscope (LSM 710, Carl Zeiss).
hEB suspension culture and growth evaluation
After a 24-hr incubation in the microwell array, hEBs were
placed in suspension culture and incubated at 37uC and 5% CO2
under gentle agitation. The differentiation medium was exchanged
every two days. Images of the hEBs were acquired when the
medium had been withdrawn from the culture dish. hEB sizes
(mean 6 S.D.) were quantified using Image Pro Plus (Media
Cybernetics, v. 4.0) based upon the measurement of the cross
sectional area of each hEB. hEB growth was monitored for 6 days
in suspension culture.
Transmission electron microscopy of cell-cell junctions
hEBs were fixed in 2% glutaraldehyde in 0.1 M cacodylate
buffer for 1 hr, and rinsed with 0.1 M cacodylate buffered with
0.2 M sucrose. The hEBs were postfixed in 2% aqueous osmium
tetroxide for 1 hr, rinsed with distilled water, dehydrated in a
graded ethanol series, and embedded in resin (EMbed 812,
Electron Microscopy Sciences). Seventy nanometer thick sections
were supported on copper grids and double stained with uranyl
acetate in methanol and with Reynolds lead citrate. Cell-cell
junctions were imaged by transmission electron microscopy (JEOL
1010, JEOL).
hEB differentiation
For cardiac differentiation, 0.14 mg/ml ascorbic acid (Sigma)
was added to the differentiation medium. For neural differentia-
tion, 0.1 mM retinoic acid (Sigma) was added to neural differen-
tiation medium, which consisted of DMEM/F12 (Invitrogen), 1%
(v/v) N2 supplement (Gibco), 0.2 mM ascorbic acid (Sigma),
10 ng/ml GDNF (PeproTech Inc.), 10 ng/ml BDNF (PeproTech
Inc.), 5 ng/ml IGF-1 (PeproTech Inc.), 1 mM cAMP (Sigma),
2 mg/ml heparin (Sigma), and 1% (v/v) nonessential amino acids
(Invitrogen). For pancreatic differentiation, 100 ng/ml activin A
(PeproTech Inc.), 10 mM nicotinamide (Sigma), and 10 ng/ml
EGF (Sigma) were added to the differentiation medium. Differ-
entiation for cardiac, neural, and pancreatic differentiation was
evaluated at 25, 26, and 18 days, respectively. Differentiation was
performed in triplicate.
Gene expression analysis
RT-PCR was performed to verify the presence of characteristic
gene markers of differentiation. RNA was extracted using Trizol
reagent (Invitrogen). RNA concentration and purity was measured
by spectrophotometry (NanoDrop 2000, Thermo-Scientific). RNA
was reverse transcribed to cDNA using the MMLV enzyme
(Moloney Murine Leukemia Virus Reverse Transcriptase, Pro-
mega). One microgram of RNA was used per sample. cDNA was
amplified using Taq polymerase (MBL). All procedures were
conducted according to the manufacturer’s instructions. Amplifi-
cation was performed using the following parameters: one cycle of
94uC for 4 min, 30–35 cycles of denaturation at 94uC for 30 sec,
and annealing at 60uC for 30 sec. The following genes were
evaluated: For cardiac differentiation: alpha actin, GATA-4,
GATA-6, Tbx-20, Tbx-5, Hand-2; For neural differentiation: Pax-
6, Nestin, Beta-3, Tyr-Hyd, GABA; For pancreatic differentiation:
Ngn3, Pdx-1, Insulin, PC-1/3, PC-2, GK, Sur-1, Kir-6.2, Glut-2,
Isl-1, SOX17, Pax-6, and Nkx-6.1. GAPDH was used as the
reference housekeeping gene.
Immunofluorencence visualization of differentiation
For immunolocalization, hEBs and differentiation cultures were
fixed with 4% (w/v) paraformaldehyde for 15 min, permeablized
with 0.3% (v/v) Triton-X 100 in PBS for 10 min, and blocked
with 0.5% (v/v) goat serum in PBS for 1 hr. Samples were
incubated with the primary antibody at 4uC overnight and then
with the secondary antibody at room temperature for 1 hr. Nuclei
were stained with 49,6-diamidino-2-phenylindole (DAPI) in PBS
for 5 min. The following primary antibodies were used to stain the
three hEB germ layers: mouse anti-alpha 1 fetoprotein (abcam,
ab3980, 5 mg/ml), rabbit anti-SOX1 (abcam, ab22572, 4 mg/ml),
and goat anti-brachyury (Santa Cruz, as-17743, 1:50). The
secondary antibodies were Cy2-AffiniPure goat anti-mouse IgG,
Fc Subclass 1 Specific (Jackson ImmunoResearch, 1:100), Cy3-
AffiniPure goat anti-rabbit IgG (H+L) (Jackson ImmunoResearch,
1:100), Cy5-conjugated AffiniPure rabbit anti-goat IgG (Jackson
ImmunoResearch, 1:100). The following primary antibodies were
used for cardiac differentiation markers: mouse monoclonal anti-
alpha cardiac actin (Sigma, A9357, 1:100) and rabbit anti-cardiac
troponin I–C (Santa Cruz, sc-98830, 1:25). The secondary
antibodies were Cy2-AffiniPure goat anti-mouse IgG, Fc Subclass
1 Specific (Jackson ImmunoResearch, 1:100), Cy3-AffiniPure goat
anti-rabbit IgG (H+L) (Jackson ImmunoResearch, 1:100). The
following primary antibodies were used for pancreatic differenti-
ation markers: insulin (Sigma, I2018, 1:100), C-peptide (Abcam,
ab30477, 1:100) and GLUT-2 (Abcam, ab54460, 1:100). The
secondary antibodies were Cy2-AffiniPure goat anti-mouse IgG,
Fc Subclass 1 Specific (Jackson ImmunoResearch, 1:100), Cy3-
AffiniPure goat anti-rabbit IgG (H+L) (Jackson ImmunoResearch,
1:100). Fluorescent images were acquired with a confocal
microscope (Leica, SP5).
Dithizone staining
A 0.01% dithizone (DTZ) (Merck) stock solution was prepared
in dimethyl sulfoxide. hEBs in the pancreatic differentiation
protocol were stained by adding DTZ stock solution to the culture
medium at 0.01% (v/v), incubating the hEBs at 37uC for
15 minutes, and then rinsing thrice in HBSS.
Western-blot analysis
Western blots were performed to detect proteins characteristic
of cardiac differentiation. Whole proteins were extracted from the
cells using radio-immunoprecipitation assay buffer (Thermo
Scientific) according to manufacturer instructions. The protein
content was quantified using the Bradford method. Absorbance at
595 nm was read using a microplate reader (Spectra max 384
Plus, Molecular Devices). Protein for each sample, 60 mg, was
loaded to perform electrophoresis in a precast 4–20% SDS-PAGE
(Ready Gel Tris-HCl Gel, BioRad) and transferred onto a
nitrocellulose membrane (Whatman) using a semi-dry method.
Proteins were detected using the following primary antibodies:
mouse monoclonal anti-alpha cardiac actin (Sigma, A9357,
1:1,000), rabbit anti-cardiac troponin I–C (Santa Cruz, sc-
98830, 1:1,000), and rabbit anti-glyceraldehyde-3-phosphate
dehydrogenase (Millipore, MAB374, 1:850). Incubations were
performed overnight at 4uC. The secondary antibodies used were
anti-Rabbit IgG, horseradish peroxidase-linked whole Ab (GE
Healthcare, NA934, 1:10,000) and anti-mouse IgG, horseradish
peroxidase-linked whole Ab (GE Healthcare, NA931, 1:10,000).
Statistical analysis
hEB cross sectional area data were analyzed using linear
regression, with ROCKi, centrifugation (spin), and day as
Embryoid Body Formation without ROCK Inhibitor
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independent categorical variables (SAS v. 9.3, SAS Institute).
Two-way interactions were included. Model assumptions were
checked graphically and were met for the BG01V/hOG and the
H9 hEB data. Least squares means, which control for other model
variables, were calculated. Mean differences between treatments
were examined using Tukey’s adjustment for multiple comparisons
to control type I error rate. The significance level was set at
a=0.05.
Results
hESC seeding density for hEB formation
hEB formation from dissociated hESC suspensions was tested
using non-adhesive hydrogel microwell arrays. The effect of hESC
seeding density on hEB formation was examined. The hESCs
were suspended in the culture medium, and the molds were seeded
over the range of 10,000 to 35,000 hESCs per microwell in
increments of 5,000 hESCs. Formation of hEBs was tested under a
total of four treatment conditions (ROCKi: ROCK inhibitor;
Spin: centrifugation): -ROCKi/-spin, -ROCKi/+spin, +ROC
Ki/-spin, and +ROCKi/+spin. The hEBs were transferred from
the molds to suspension culture for growth and differentiation
assays after 24 hrs of incubation.
The minimum input cell number per microwell required to
form a hEB that is able to maintain structural integrity in
suspension culture was approximately 10,000 cells per microwell
for the BG01V/hOG hESC line, and 15,000 cells per microwell
for the H9 line. For each hESC line, there was a range of input cell
number (10,000 to 25,000 hESCs per microwell for the BG01V/
hOG line, and 15,000 to 30,000 hESCs per microwell for the H9
line) that allowed hEB formation in the agarose hydrogel
microwell molds. Input cell numbers that fell off the lower end
of the range resulted in disintegration of hEBs within the first two
to three days in suspension culture. hESCs failed to aggregate
when input cell numbers exceeded the higher end of the range
regardless of the presence of ROCKi and/or centrifugation. For
all the subsequent investigations, 15,000 hESCs/microwell for the
BG01V/hOG cells, and 25,000 hESCs/microwell for the H9 cells
were seeded. For each experiment, the same cell suspension was
used to form hEBs for each of the four conditions for each cell line.
Neither ROCKi nor centrifugation was required for hEB
formation for both hESC cell lines
For the BG01V/hOG cells, under each of the four conditions,
condensation of the BG01V/hOG cell suspension was visible after
6 hrs of incubation in the microwell arrays (Fig. 1a). The cells
became more densely aggregated and compact over time in
incubation. After 24 hrs of incubation, hEBs could be readily transfer
to other cell cultureware (Fig. 1b). Notably, neither ROCKi nor
centrifugation was required for hEB formation. The formed hEBs
were uniform in sizes (Table 1) and nearly spherical for each
treatment condition (Fig. 1c). Freshly formed hEBs after 24 hrs of
incubation displayed a variety of cell-cell junctions, reflecting a
complex and increasingly organized internal structure (Fig. 1d).
In concurrence, treatment with ROCKi and/or centrifugation
was not required for hEB formation by the H9 cells either.
Condensation of the hESC suspension within the microwells was
also progressive for the H9 cells. However, condensation of the
suspension occurred somewhat differently for the two hESC lines.
For the BG01V/hOG hESCs, nearly all cells in the microwell
condensed to participate in hEB formation. For H9 hESCs, a
portion of the cells did not condense, instead, they remained
loosely aggregated at the peripheral of the hEBs (Fig. 2b). At
24 hrs of incubation, hEBs were readily formed under each of the
four conditions (Fig. 2a). The formed hEBs were uniform in sizes
and spherical (Table 1 and Fig. 2a). In particular, regardless of
the condition, the hEBs were consisted of a central compact core
(Fig. 2b, arrows, showing formed hEBs under -ROCKi/-spin
condition as an example) that was surrounded by a loosely-
aggregated corona. hESCs at the core and within the corona
exhibited a high degree of viability (.90%, Fig. 2c). During the
transfer process from the microwells to the subsequent suspension
culture, cells at the corona were sloughed off. A closer examination
of the cells in the extracted hEBs indicated a high degree of
viability (.85%, Fig. 2d), suggesting the hESCs remain viable
under the all four conditions regardless of whether they participate
in the hEB formation, and that the transfer process poses little
interference to cell viability. Taken together, the non-adhesive
hydrogel microwell arrays promoted the formation of uniform-
sized, spherical hEBs from both BG01V/hOG and H9 hESCs in
the absence of either ROCKi or centrifugation.
ROCKi and/or centrifugation was associated with hEB size
differences for both hESC cell lines
Next, we evaluated whether ROCKi and/or centrifugation
treatment during hEB formation would result in differences in hEB
sizes. The sizes (cross-sectional areas) of the hEBs formed under
different treatment conditions were measured over time at 2, 4, and
6 days in suspension culture for the two hESC cell lines. For the
BG01V/hOG cells, treatment with ROCKi during hEB formation
was associated with greater hEB cross-sectional area than those –
ROCKi groups when controlling for centrifugation and time (p,
0.001) (Fig. 3a). Treatment with centrifugation was also associated
with greater hEB cross-sectional area than those no-centrifugation
(–spin) groups when controlling for ROCKi and time (p=0.011).
There was a significant synergistic effect of ROCKi and centrifu-
gation treatment on increasing the sizes of resultant hEBs. hESCs
treated with both ROCKi and centrifugation (+ROCKi/+spin
group) had a greater cross-sectional area than hESCs treated with
ROCKi (p,0.001) or centrifugation alone (p,0.001) or untreated
hESCs (-ROCKi/-spin group, p,0.001) (detailed model results in
Table S1). In all the four treatment groups, the hEB cross-sectional
area did not vary over time in suspension culture.
For the H9 cells, treatment with ROCKi during hEB formation
was associated with greater area than those –ROCKi groups when
controlling for centrifugation and time (p,0.001) (Fig. 3b).
Treatment with centrifugation was associated with a smaller
cross-sectional area than those –spin groups when controlling
ROCKi and time (p=0.033). There was a significant interaction
between ROCKi and centrifugation treatment (p=0.042). H9
hESC treated with ROCKi alone had a greater area than hESC
treated with both ROCKi and centrifugation (+ROCKi/+spin
group, p=0.017), centrifugation alone (p,0.001), or untreated
hESCs (-ROCKi/-spin group, p,0.001) (detailed model results in
Table S2). There was a significant association between cross-
sectional area and day, with area increasing over time for all the
four groups (p,0.001 for all time point comparisons). There was
also a significant interaction between ROCKi treatment and day
(p,0.001) with a greater increase in area over time in the ROCKi
treated hEBs. No significant association was found between
centrifugation and culture day.
hEBs formed under the -ROCKi/-spin condition expressed
proteins representative of all the three developmental
germ layers
Once we demonstrated uniform-sized spherical hEBs were able
to form in our hydrogel microwells under the -ROCKi/-spin
Embryoid Body Formation without ROCK Inhibitor
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condition, all subsequent investigations were confined to the hEBs
formed under this condition. To confirm the pluripotency of the
formed hEBs, it is important to determine whether the hEBs are
able to generate representatives of the three developmental germ
layers. Immunofluorescent staining of the hEBs (formed from the
BG01V/hOG and the H9 hESC lines) at 20 days in suspension
culture revealed robust expression of proteins characteristic of all
the three developmental germ layers, including Alpha Fetoprotein
(AFP, endoderm-specific), SOX1 (ectoderm-specific), and Brachi-
ury (mesoderm-specific) (Fig. 4a,b). These data confirm that the
formed hESC aggregates are indeed hEBs since they possess the
fundamental properties of embryoid bodies by giving rise to all the
three developmental germ layers within a timeframe that is
comparable to that of in vivo embryogenesis (i.e., in vivo
gastrulation ends followed by the formation of the three
developmental germ layers at around 20 days after fertilization),
and that they are pluripotent, having the potential to differentiate
into a full spectrum of lineages associated with each germ layer.
The EB stage represents the onset of hESC differentiation.
hEBs formed under the -ROCKi/-spin condition
differentiated into tissue lineages specific to each germ
layer
To further confirm that the hEBs formed under the -ROCKi/-
spin condition are able to differentiate into tissue lineages specific
to each of the three embryonic germ layers, we applied standard
differentiation protocols to induce their differentiation towards
neural (ectoderm-specific), cardiac (mesoderm-specific), and pan-
creatic (endoderm-specific) lineages, respectively. We first tested
the hEBs derived from the BG01V/hOG cells under the
-ROCKi/-spin condition. RT-PCR examination of the cells
derived from these hEBs after respective differentiation protocol
demonstrated unambiguous expression of a complete panel of
lineage-specific genes for each germ layer-specific lineage
(Fig. 5a). Genes that are characteristic of neural lineage include
neuroectodermal markers expressed during neural plate and
neural tube-like structure (NT) formation such as Pax-6 (a stage-
specific markers for neuro-ectodermal differentiation [30]) and
Nestin (an intermediate filament protein expressed in dividing cells
during the early stages of development in the central nervous
system (CNS) [31] and the peripheral nervous system (PNS)
[32,33]), and markers for mature neural lineages associated with
more differentiated neuronal stage such as Beta-3 (b-III-tubulin)
(an adrenergic receptor [34]), TYR-HYD (Tyrosin Hydroxylase,
an enzyme responsible for catalyzing the conversion of the amino
acid L-tyrosine to dihydroxyphenylalanine (DOPA)[35]), and
GABA (c-Aminobutyric acid, the chief inhibitory neurotransmitter
in the mammalian CNS that regulates neuronal excitability
[36,37]). Expression of the genes associated with more mature
neuronal lineages (such as Beta-3, TYR-HYD, and GABA) at
Figure 1. BG01V/hOG cells formed hEBs in the microwells at a cell seeding density of 15,000 hESCs per microwell. (a) Condensation of
the hESC suspension within the microwells was progressive and evident after 6 hrs of incubation. (b) hEBs were compact and spherical and be able
to be extracted intact from the microwells after 24 hrs of incubation. (c) The freshly extracted hEBs formed under four different conditions (ROCKi:
ROCK inhibitor; Spin: centrifugation). (d) Internal structural organization among the cells within the freshly extracted hEBs (formed under -ROCK/-spin
condition) was demonstrated by the presences of cell-cell junctions, i.e., adherence junctions (AJ), gap junctions (GJ), desmosomes (D), and tight
junctions (TJ), in TEM images. All treatments were performed with aliquots from the same cell suspension. Microwell diameter 820 mm. Scale bars
500 mm.
doi:10.1371/journal.pone.0100742.g001
Table 1. Cross-sectional areas (mm2) of the hEBs formed after 24 hrs of incubation.
-ROCKi/-spin -ROCKi/+spin +ROCKi/-spin +ROCKi/+spin
BG01V/hOG 500591 (626830) 406089 (617808) 628116 (623271) 684089 (619302)
H9 154126 (66759) 156055 (67104) 183059 (65553) 138410 (69850)
doi:10.1371/journal.pone.0100742.t001
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much higher levels when compared to those for early neural
markers (such as Pax-6 and Nestin) could indicate that the cells
derived from the BG01V/hOG hEBs after neural differentiation
are committed to a neural fate rather than residing at a
neuroepithelial or neural progenitor stage.
For the cardiac differentiation, the cells expressed genes that are
critical to either initiate cardiac specification and/or maintain
cardiac phenotype. These include cardiac a-actin, a major
constituent of the contractile apparatus that is present in muscle
tissues [38]; HAND2, which is asymmetrically expressed in the
developing ventricular chambers and plays an essential role in
cardiac morphogenesis [39]; TBX5, encodes a protein that plays a
role in heart development [40]; TBX20 that is essential for early
heart development [41]; GATA4, a protein that regulates genes
involved in embryogenesis and myocardial differentiation/func-
tion [42,43]; and GATA6 that is associated with embryonic
cardiac development [43]. The higher expression levels of the
molecular markers for early cardiac development and morpho-
genesis (e.g., GATA4, GATA6, TBX20, and HAND2) when
compared to those of more chamber-specific cardiac markers (e.g.,
a-actin and TBX5) may suggest the output cells after cardiac
differentiation of the hEBs that were produced under the
-ROCKi/-spin condition retained the potential to differentiate
into a wide range of cardiac precursors. Cardiac differentiation
was also demonstrated by the presence of the cardiac a-actin and
troponin proteins detected by western blot (Fig. 5b).
Gene expressions were consistent with pancreatic lineage after
pancreatic (endodermal) differentiation of the BG01V/hOG cells
(Fig. 5a). Two sets of pancreatic b-cell-specific genes that either
encode proteins of the characteristic structural components of
pancreatic b-cells or are the key to de novo synthesis of insulin
were detected. Genes in the first category include Ngn3, a basic
helix-loop-helix transcription factor that is critical for the
development of the endocrine cells of the islets [44]; Glut-2, an
Figure 2. H9 hESCs formed hEBs in the microwells at a cell seeding density of 25,000 hESCs per microwell. (a) Freshly extracted hEBs
formed under four different conditions in microwells after 24 hrs of incubation. (b) A closer look at hEBs formed under -ROCK/-spin condition after
24 hrs of incubation before extraction indicated the presences of a compact core (arrows) and a loosely-aggregated corona. (c) Live-dead staining of
the formed hEBs under -ROCK/-spin condition after 24 hrs of incubation before transfer to suspension culture indicated high viability (.90%) of
hESCs both at the core and the corona (SYTO 10 green-fluorescent nucleic acid stain for all cells; DEAD Red (ethidium homodimer-2) nucleic acid stain
for dead cells). (d) Confocal microscopic images of live/dead staining of freshly extracted hEBs (formed under -ROCK/-spin condition) indicated high
viability (.85%) of the hESCs. Note that cells at the corona of the hEBs were sloughed off during the transfer process. Scale bars 500 mm.
doi:10.1371/journal.pone.0100742.g002
Figure 3. Sizes (the cross-sectional areas, mean ± s.e.m.) over time in suspension culture of hEBs formed under the four different
conditions for the (a) BG01V/hOG and (b) H9 cells.
doi:10.1371/journal.pone.0100742.g003
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integral plasma membrane glycoprotein of islet beta cells which
has been suggested as a glucose sensor [45]; Glucokinase (GK), an
enzyme that plays an important role in the regulation of
carbohydrate metabolism as a glucose sensor by facilitating
phosphorylation of glucose to glucose-6-phosphate [46]; and
Kir-6.2, pancreatic b-cell-expressing adenosine triphosphate
(ATP)-sensitive potassium (KATP) channels that are needed for
normal insulin secretion [47]. Genes pertinent to insulin secretion
include PDX-1 (also known as Insulin Promoter Factor 1), a
transcriptional activator of several genes necessary for pancreatic
development, b-cell maturation, and insulin secretion [48]; PC-1/
3 and PC-2, two key enzymes (endopeptidases or prohormone
convertases) possessing a proinsulin-processing endopeptidase
activity through cleavage of specific sites on proinsulin to convert
to insulin [49]; Sur-1, a protein that modulates KATP channels and
insulin release [50]; and Islet-1, a protein that binds an enhancer
region of the insulin gene, among others, which may play an
important role in regulating insulin gene expression [51]. The
presence of insulin was also clear (Fig. 5a).
In parallel, gene expression was characteristic of pancreatic
lineage after pancreatic differentiation of the H9 hEBs. After 21
days of pancreatic differentiation with our protocol, over 90% of
the cells were insulin-positive, as evidenced by the positive staining
for Dithizone (DTZ) (Fig. 6b DTZ+ in dark red color), a specific
enzyme that indicates the presence of insulin [52]. RT-PCR
analysis of the cells revealed expressions of key pancreatic b-cell-
specific genes, including insulin, Pdx-1, PC-1/3 and PC-2, GK,
Ngn3, Pax-6, Sur-1, Glut-2, and Kir-6.2 (Fig. 6a). Immunoflu-
orescence double staining of insulin and C-peptide revealed their
co-localization on the insulin-producing cells (Fig. 6c), confirming
a de novo synthesis of insulin that is indicative of the full
functionality of our differentiated cells. C-peptide is a by-product
when proinsulin is converted to insulin. In all, after pancreatic
differentiation, the H9 EBs that were produced under the -
ROCKi/-spin condition were able to give rise to mature
functional insulin-producing pancreatic b-cells, an endodermal-
specific lineage.
Figure 4. hEBs (formed under -ROCK/-spin condition) expressed proteins characteristic of all the three developmental germ layers.
At 20 days in suspension culture, the hEBs were positive for Alpha Fetoprotein (AFP, endoderm-specific), SOX1 (ectoderm-specific), and brachiury
(mesoderm-specific) for both the (a) BG01V/hOG and (b) H9 cell lines. Cell nuclei were stained in blue with DAPI.
doi:10.1371/journal.pone.0100742.g004
Figure 5. BG01V/hOG hEBs (formed under -ROCK/-spin condition) differentiated into tissue lineages specific to each of the three
embryonic germ layers. (a) RT-PCR analysis demonstrated gene expression profiles that are specific to representative lineages associated with
each germ layer, i.e., neural (ectoderm), pancreatic (endoderm), and cardiac (mesoderm) lineages. (b) At 25 days when treated with the cardiac
differentiation protocol, western blot confirmed expressions of cardiac a-actin and cardiac troponin-C proteins that are representative of cardiac
lineage.
doi:10.1371/journal.pone.0100742.g005
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Discusssion
In this study, we have developed a simple technology based
upon non-adhesive hydrogel microwell arrays for the formation of
hEBs from dissociated single cell suspension of hESCs. We have,
for the first time, demonstrated robust hEB formation from
singularized hESCs in the absence of ROCKi or centrifugation.
For both hESC cell lines that were tested, i.e., BG01V/hOG and
H9, within a range of cell seeding density per microwell, uniform-
sized spherical hEBs were formed under no-ROCKi and no-spin
condition, and extracted intact from the microwells for subsequent
culture/differentiation. The hEBs exhibited organized internal
tissue-level structures and expressed proteins distinctive for all
three embryonic germ layers. Exposure of the hEBs to directed
differentiation protocol led to their specifications into lineages
characteristic of each germ layer.
Dissociated single cell suspension represents a more uniform
inputting population for hEB formation when compared to cell
colonies/clumps that are widely variable in terms of sizes and pre-
existing organizations [53]. Single cell suspension also allows strict
control of EB sizes by seeding defined numbers of cells per
microwell for the formation of one discrete EB per well. However,
when present in the form of dissociated single cell suspension,
hESCs have displayed extremely low viability [54,55], possibly due
to the inability to establish cell-cell contact. hESCs cultured in 3-D
microwell arrays have demonstrated higher expression of E-
cadherins than cells on 2-D substrates. In addition, hEBs formed
from colonies of hESCs cultured in 3-D microwells displayed
much higher levels of Wnt signaling than hEBs formed from
hESCs in 2-D cultures [56]. Both E-cadherins [26] and Wnt
signaling are implicated in cell junctions. These results suggest that
3-D microwells facilitate cell-cell contact in hESCs. The study that
led to direct correlation between cell-cell contact and cell viability
was performed on cells other than hESCs, e.g., pancreatic beta-
cells, which exhibited multi-fold increase in viability in the
presence of cell-cell contact formed during aggregation into
clusters in 3-D microwells when compared to singularized cells of
the same type [57]. Therefore, one challenge to be addressed in
any techniques for effective hEB formation starting from
dissociated hESCs is to allow quick and controlled aggregation
to minimize the residential time of hESCs in the form of
dissociated single cells, and increase cell-cell interactions.
To this end, we have developed deep round-bottom non-
adhesive hydrogel microwell arrays for hEB formation. Non-
adhesive or low-adherence microwells have been previously used
in the attempts of other labs to generate hEBs with variable results.
Some studies have shown moderate success, e.g., hEBs were able
to form in microwells after forced aggregation via centrifugation
(‘‘the spin EBs’’), but the survival and differentiation remained
unpredictable [28]. Others have shown disintegration of the hESC
cell pellets (formed without centrifugation) into undefined variable
3-D structures that were difficult to be extracted from the
microwells [15]. Centrifugation has been shown to cause
mechanical injury to cells, destruct cell membranes, and may
alter the stem characteristics of stem cells and their differentiation
potential [58]. It also prevents scale-up and automation of the
process due to manual procedure and intense labor in sample
handling. Recently, ROCKi Y-27632 has been adapted to
enhance the survival of singularized hESCs in culture while
preserving their pluripotency [19]. In the presence of ROCKi, but
the absence of centrifugation, coherent hEBs were able to form
from dissociated hESCs that were cultured on the Matrigel,
indicating the effectiveness of ROCKi on hEB formation [15].
The survival-promoting effect of ROCKi on dissociated hESCs
was most prominent during the initial stage following the
dissociation/replating procedure [19], which represents a critical
time period for cell survival. The underlying mechanism
responsible for the observed effect of ROCKi is not known, yet
it may be related to its ability to amplify anti-apoptotic signals
upon cellular detachment and dissociation [26,59], likely in an
anti-apoptotic manner that is similar to the survival-promoting
effect of neurotrophins on hESCs [55]. Several studies have
demonstrated successes in homogenous and synchronized hEB
formation from singularized hESCs in the presence of ROCKi
[19]. However, ROCKi is a xenofactor, and even short-term
exposure of hESCs to ROCKi has been shown to bias cell fate
toward residual pluripotency, rendering the cells unsuitable for
patient therapies [8]. To date, the present study is the first report
Figure 6. H9 hEBs (formed under -ROCK/-spin condition) differentiated into pancreatic lineage at 18 days when treated with the
pancreatic differentiation protocol. (a) RT-PCR analysis demonstrated expression of key pancreatic lineage-specific genes. (b) Over 90% of the
cells were insulin-positive, as evidenced by positive staining for dithizone (DTZ) in dark red. (c) Immunostaining of the cells revealed co-localization
(in yellow) of insulin and C-peptide. Cell nuclei were stained in blue with DAPI.
doi:10.1371/journal.pone.0100742.g006
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on successful generation of uniform-sized synchronized hEBs from
singularized hESCs in the absence of centrifugation or ROCKi.
The fabricated deep round-bottom microwell arrays of agarose, a
neutral hydrophilic polymer that is non-adherent to cells, had
allowed quick robust aggregation among the singularized hESCs
for hEB formation without the need for centrifugation or ROCKi.
Successful hEB formation occurred only within a specific range
of input hESC cell number per microwell, which was similar for
both hESC lines. Use of a higher or a lower number of cells
outside of the range resulted in the failure of the hESCs to
aggregate, or the formation of loose aggregates that disintegrated
immediately when transferred to suspension culture. This cell
number dependence was a feature of both hESC lines whether or
not the cells were treated with ROCKi or centrifugation. Our
experiments used a deep round-bottom microwell of a single size;
additional testing will be required to determine if the cell number
range for successful hEB formation varies with well size or
geometry. Treatment of the hESCs with ROCKi and/or
centrifugation altered hEB sizes. ROCKi was associated with
larger hEBs for both cell lines. Centrifugation was associated with
larger hEBs for the BG01V/hOG line and smaller hEBs for the
H9 line. These size differences are evidence of the immediate
effects of ROCKi and/or centrifugation treatments on the
resultant hEBs. Our hEB formation strategy eliminates the need
for these treatments and any down-stream effects that they may
have.
Further demonstration of the ability of the hEBs to generate all
three embryonic germ layers confirmed the pluripotency of the
hEBs. When exposed to specific lineage differentiation protocols,
the hEBs differentiated into each of the embryonic cell lineages.
These results have suggested that our microwell array-based hEB
formation strategy under the no-ROCKi no-spin condition has
indeed produced hEBs rather than hESC aggregates or colonies,
and it does not interfere with the differentiation potential or
pluripotency of the hEBs to deliver a full spectrum of clinically-
relevant lineages for cell therapies. The findings have also justified
the use of the formed hEBs as a model system that recapitulates
the early stages of development for in vitro organogenesis and
research on human developmental biology.
In addition to maintaining high viability of hESCs during hEB
formation, the other challenge is to improve the efficiency,
homogeneity, and reproducibility of the process [3,22]. Efficiency
is important to achieve high through-put, automated, and scalable
production of hEBs for research and clinical interests. To date, the
major barrier to improve efficiency is the centrifugation step for
forced aggregation. By eliminating this step, this non-adhesive
microwell array-based approach represents a trend in high
through-put technology for process development. 80% confluent
hESCs cultured in a 6-well plate may provide sufficient numbers of
cells to seed 280 microwells of 820 mm in diameter, therefore,
allowing production of 280 hEBs at the same time. General cell
replacement therapy requires nearly 108,109 cells per patient per
administration [60]. Given the number of cells contained in each
hEB, the yield of directed differentiation, and the viability and
functionality of the transplanted cells, each administration per
patient requires approximately 50,70 6-well plates of hESC
culture for hEB preparation using our microwell arrays. The
labor- and space-efficient, and scalable technology that we have
developed in the present study for hEB production in large
quantities would fuse into the mainstream of research efforts in our
lab on establishing fully automatic robotic platform for the culture
and directed differentiation of human pluripotent stem cells, such
as hESCs and hiPSCs (human induced pluripotent stem cells).
Thousands of the microwell arrays can be fitted into small space
and automatically processed in the same way without the need for
ROCKi or centrifugation, thus ensuring the homogenecity and
synchronization of the resultant hEBs as opposed to heterogeneous
and unsynchronized output populations that are associated with
conventional hEB formation protocols [21,61]. The produced
hEBs in large batches may be further induced to generate large
numbers of differentiated cells for clinical-applicable cell therapies.
Throughout the study, there are several notable differences
between the two hESC cell lines, i.e., BG01V/hOG and H9. In
the BG01V/hOG cells, nearly all of the hESCs in each microwell
condensed to form a robust hEB. In the H9 cells, the cells
remained viable in culture in the microwells; however, only a
portion of the cells in each microwell formed a dense core while
the remaining cells formed a loose halo of the aggregate, which
was then sloughed off during transfer. As a result, under the same
treatment condition, hEBs formed from H9 line seemed to be less
compact. Due to the fact that both hESC cell lines underwent the
same treatment for hEB formation, the observed differences are
cell line-dependent rather than technology-dependent. Differences
in hEB formation among hESC lines have been reported
previously [27]. Parallel interline comparison of several hESC
lines in terms of hEB formation (from dissociated single cells with
centrifugation), growth, and cardiomyocyte differentiation impli-
cated the derivation and culture history of each line as a source of
variability [27]. Since BG01V/hOG and H9 are independently
derived hESC lines [62,63], the observed differences may be
linked to both inherent genetic differences and epigenetic
differences [27], even though differences in input cell density
and the culture medium may also play roles [64]. Additional
testing will be required to determine the generic interline utility of
this deep round-bottom microwell-based strategy in hEB forma-
tion among other independently-derived hESC lines without
ROCKi or centrifugation treatment.
Conclusion
Taken together, we have demonstrated the utility of non-
adhesive agarose hydrogel microwell arrays for the formation of
hEBs from dissociated single cell suspension of hESCs in the
absence of ROCKi or xeno factors or the rate-limiting step of
centrifugation – in a scalable and cost-effective manner. The
formed hEBs were homogeneous in size and shape without pre-
existing cell-cell contacts, and developed the three embryonic
germ layers and tissues derived from each of the germ layers. Our
strategy will directly support automated, large-scale production of
hEBs or hESC-derived cells required for clinical, research, or
therapeutic applications.
Supporting Information
Figure S1 (A) Image of a Teflon stamp with micronipple
arrays that was used to create the hydrogel microwells
for the hEB formation; (B) Low-melting-point agarose
was used to make microwells to form hEBs. The agarose
was dissolved in 1X phosphate buffered saline (PBS) at 100uC and
pipetted into the culture ware. After approximately 10 min, the
agarose gelled, the Teflon micronipple stamp was withdrawn, and
hydrogel microwells with replicative geometry of the micronipple
stamp were formed into the gel; A 50 ml dissociated single-cell
suspension of hESCs was dispensed into each mold to evenly fill all
the microwells. After 24 hours of incubation, the formed hEBs
were taken out from microwells, imaged, and transferred to
suspension culture.
(TIF)
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Table S1 LSMeansa and Tukeys post hoc comparisons
for the cross sectional area of hEBs formed using
approx. 15,000 BG01V/hOG hESC/well. Twenty-eight to
forty-four hEBs were evaluated per group at each time point.
(DOC)
Table S2 LSMeansa and Tukeys post hoc comparisons
for the cross sectional area of hEBs formed using
approx. 25,000 H9 hESC/well. Seventy hEBs were evaluated
per group at each time point.
(DOC)
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